An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder - PubMed (original) (raw)
. 2004 Aug 1;104(3):735-43.
doi: 10.1182/blood-2003-10-3413. Epub 2004 Apr 6.
Affiliations
- PMID: 15069016
- DOI: 10.1182/blood-2003-10-3413
Free article
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder
Michael B Jordan et al. Blood. 2004.
Free article
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder with familial and acquired forms. The familial form is associated with mutations in the perforin gene and both forms are associated with severe defects in lymphocyte cytotoxic function. We examined perforin-deficient mice as a model of HLH in order to gain insight into this poorly understood disorder. While these mice do not spontaneously develop HLH-like symptoms, we found that they manifest all of the features of HLH after infection with lymphocytic choriomeningitic virus (LCMV). Following LCMV infection, perforin-deficient mice develop fever, splenomegaly, pancytopenia, hypertriglyceridemia, hypofibrinogenemia, and elevation of multiple serum cytokine levels, and hemophagocytosis is evident in many tissues. Investigation into how this phenotype develops has revealed that CD8+ T cells, but not natural killer (NK) cells, are necessary for the development of this disorder. Cytokine neutralization studies have revealed that interferon gamma (IFNgamma) is uniquely essential as well. Finally, the excessive amount of IFNgamma seen in affected mice appears to be driven by increased antigen presentation to CD8+ T cells. These studies provide insight into the pathophysiology of HLH, and provide new targets for specific therapeutic intervention in this fatal disorder.
Similar articles
- Trigger-dependent differences determine therapeutic outcome in murine primary hemophagocytic lymphohistiocytosis.
Gather R, Aichele P, Goos N, Rohr J, Pircher H, Kögl T, Zeiser R, Hengel H, Schmitt-Gräff A, Weaver C, Ehl S. Gather R, et al. Eur J Immunol. 2020 Nov;50(11):1770-1782. doi: 10.1002/eji.201948123. Epub 2020 Jun 2. Eur J Immunol. 2020. PMID: 32419134 - IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
Humblet-Baron S, Franckaert D, Dooley J, Bornschein S, Cauwe B, Schönefeldt S, Bossuyt X, Matthys P, Baron F, Wouters C, Liston A. Humblet-Baron S, et al. J Allergy Clin Immunol. 2016 Jul;138(1):200-209.e8. doi: 10.1016/j.jaci.2015.12.1314. Epub 2016 Mar 4. J Allergy Clin Immunol. 2016. PMID: 26947179 - IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
Humblet-Baron S, Franckaert D, Dooley J, Ailal F, Bousfiha A, Deswarte C, Oleaga-Quintas C, Casanova JL, Bustamante J, Liston A. Humblet-Baron S, et al. J Allergy Clin Immunol. 2019 Jun;143(6):2215-2226.e7. doi: 10.1016/j.jaci.2018.10.068. Epub 2018 Dec 19. J Allergy Clin Immunol. 2019. PMID: 30578871 Free PMC article. - CD8+ T Cell Biology in Cytokine Storm Syndromes.
Sekine T, Galgano D, Casoni GP, Meeths M, Cron RQ, Bryceson YT. Sekine T, et al. Adv Exp Med Biol. 2024;1448:129-144. doi: 10.1007/978-3-031-59815-9_10. Adv Exp Med Biol. 2024. PMID: 39117812 Review. - Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences.
Ishii E, Ohga S, Imashuku S, Kimura N, Ueda I, Morimoto A, Yamamoto K, Yasukawa M. Ishii E, et al. Crit Rev Oncol Hematol. 2005 Mar;53(3):209-23. doi: 10.1016/j.critrevonc.2004.11.002. Crit Rev Oncol Hematol. 2005. PMID: 15718147 Review.
Cited by
- JAK Inhibitors in Cytokine Storm Syndromes.
Keenan C, Albeituni S, Nichols KE, Hines M. Keenan C, et al. Adv Exp Med Biol. 2024;1448:583-600. doi: 10.1007/978-3-031-59815-9_39. Adv Exp Med Biol. 2024. PMID: 39117841 Review. - Macrophage activation syndrome in a patient with pulmonary inflammatory myofibroblastic tumour.
Kuppe C, Westphal S, Bücher E, Moeller MJ, Heintz B, Schneider ME, Floege J. Kuppe C, et al. Allergy Asthma Clin Immunol. 2012 May 20;8(1):6. doi: 10.1186/1710-1492-8-6. Allergy Asthma Clin Immunol. 2012. PMID: 22607519 Free PMC article. - Renal cell carcinoma with secondary hemophagocytic syndrome: A case report.
Chao CT, Kao CC, Lee SY, Ho SJ, Jhuang YJ, Li LH, Kao TW. Chao CT, et al. Can Urol Assoc J. 2012 Apr;6(2):E64-6. doi: 10.5489/cuaj.10188. Can Urol Assoc J. 2012. PMID: 22511436 Free PMC article. - Deregulated JAK3 mediates growth advantage and hemophagocytosis in extranodal nasal-type natural killer/T-cell lymphoma.
Picod A, Martino S, Cervera P, Manuceau G, Arca M, Wittner M, Zhang Y, Liang H, Beghi F, Solary E, Louache F, Coppo P. Picod A, et al. Haematologica. 2022 Sep 1;107(9):2218-2225. doi: 10.3324/haematol.2021.280349. Haematologica. 2022. PMID: 35511669 Free PMC article. No abstract available. - HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
McNerney KO, Si Lim SJ, Ishikawa K, Dreyzin A, Vatsayan A, Chen JJ, Baggott C, Prabhu S, Pacenta HL, Philips C, Rossoff J, Stefanski HE, Talano JA, Moskop A, Verneris M, Myers D, Karras NA, Brown P, Bonifant CL, Qayed M, Hermiston M, Satwani P, Krupski C, Keating AK, Baumeister SHC, Fabrizio VA, Chinnabhandar V, Egeler E, Mavroukakis S, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. McNerney KO, et al. Blood Adv. 2023 Jun 27;7(12):2758-2771. doi: 10.1182/bloodadvances.2022008893. Blood Adv. 2023. PMID: 36857419 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials